Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhanced immune reaction resulting from co-vaccination of WT1 helper peptide assessed on PET-CT.
Nakata J, Isohashi K, Morimoto S, Itou R, Kamiya T, Matsuura A, Nakajima H, Fujiki F, Nishida S, Hasii Y, Hasegawa K, Nakatsuka S, Hosen N, Tsuboi A, Oka Y, Kumanogoh A, Shibano M, Munakata S, Oji Y, Hatazawa J, Sugiyama H. Nakata J, et al. Among authors: hatazawa j. Medicine (Baltimore). 2020 Sep 25;99(39):e22417. doi: 10.1097/MD.0000000000022417. Medicine (Baltimore). 2020. PMID: 32991475 Free PMC article.
Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
Chiba Y, Kinoshita M, Okita Y, Tsuboi A, Isohashi K, Kagawa N, Fujimoto Y, Oji Y, Oka Y, Shimosegawa E, Morita S, Hatazawa J, Sugiyama H, Hashimoto N, Yoshimine T. Chiba Y, et al. Among authors: hatazawa j. J Neurosurg. 2012 Apr;116(4):835-42. doi: 10.3171/2011.12.JNS111255. Epub 2012 Jan 13. J Neurosurg. 2012. PMID: 22242671 Clinical Trial.
Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET.
Kato H, Okuno T, Isohashi K, Koda T, Shimizu M, Mochizuki H, Nakatsuji Y, Hatazawa J. Kato H, et al. Among authors: hatazawa j. J Cereb Blood Flow Metab. 2021 Feb;41(2):369-379. doi: 10.1177/0271678X20911469. Epub 2020 Mar 13. J Cereb Blood Flow Metab. 2021. PMID: 32169013 Free PMC article.
Imaging Assessment of Tumor Response in the Era of Immunotherapy.
Nakata J, Isohashi K, Oka Y, Nakajima H, Morimoto S, Fujiki F, Oji Y, Tsuboi A, Kumanogoh A, Hashimoto N, Hatazawa J, Sugiyama H. Nakata J, et al. Among authors: hatazawa j. Diagnostics (Basel). 2021 Jun 5;11(6):1041. doi: 10.3390/diagnostics11061041. Diagnostics (Basel). 2021. PMID: 34198874 Free PMC article. Review.
A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data.
Morita S, Oka Y, Tsuboi A, Kawakami M, Maruno M, Izumoto S, Osaki T, Taguchi T, Ueda T, Myoui A, Nishida S, Shirakata T, Ohno S, Oji Y, Aozasa K, Hatazawa J, Udaka K, Yoshikawa H, Yoshimine T, Noguchi S, Kawase I, Nakatsuka S, Sugiyama H, Sakamoto J. Morita S, et al. Among authors: hatazawa j. Jpn J Clin Oncol. 2006 Apr;36(4):231-6. doi: 10.1093/jjco/hyl005. Epub 2006 Apr 12. Jpn J Clin Oncol. 2006. PMID: 16611662 Clinical Trial.
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme.
Izumoto S, Tsuboi A, Oka Y, Suzuki T, Hashiba T, Kagawa N, Hashimoto N, Maruno M, Elisseeva OA, Shirakata T, Kawakami M, Oji Y, Nishida S, Ohno S, Kawase I, Hatazawa J, Nakatsuka S, Aozasa K, Morita S, Sakamoto J, Sugiyama H, Yoshimine T. Izumoto S, et al. Among authors: hatazawa j. J Neurosurg. 2008 May;108(5):963-71. doi: 10.3171/JNS/2008/108/5/0963. J Neurosurg. 2008. PMID: 18447714 Clinical Trial.
479 results